Home  |  Archive  |  Online Submission  |  News & Events  |  Subscribe  |  APFA  |  Society  |  Links  |  Contact Us  |  中文版

Ahead of print
Authors' Accepted
Current Issue
Special Issues
Browse by Category

Manuscript Submission

Online Submission
Online Review
Instruction for Authors
Instruction for Reviewers
English Corner new!

About AJA

About AJA
Editorial Board
Contact Us

Resources & Services

Email alert

Download area

Copyright licence
EndNote style file
Manuscript word template
Guidance for AJA figures
    preparation (in English)

Guidance for AJA figures
    preparation (in Chinese)

Proof-reading for the

AJA Club (in English)
AJA Club (in Chinese)


Societies & Institutes
Databases & Libraries
Other links


Volume 13, Issue 3 (May 2011) 13, 476–480; 10.1038/aja.2010.143

Altered expression patterns of syndecan-1 and -2 predict biochemical recurrence in prostate cancer

Rodrigo Ledezma1, Federico Cifuentes1, Iván Gallegos2, Juan Fullá1, Enrique Ossandon3, Enrique A Castellon1 and Héctor R Contreras1

1 Laboratory of Molecular and Cellular Andrology, Physiology and Biophysics Program. Institute of Biomedical Sciences, Faculty of Medicine, University of Chile, Santiago 70005, Chile
2 Pathology Service, Clinic Hospital, University of Chile, Santiago 70005, Chile
3 Urology Service, Clinic Hospital, University of Chile, Santiago 70005, Chile

Correspondence: Dr HR Contreras, (hcontrer@med.uchile.cl)

Received 12 April 2010; Revised 25 July 2010; Accepted 3 September 2010; Published online 14 February 2011


The clinical features of prostate cancer do not provide an accurate determination of patients undergoing biochemical relapse and are therefore not suitable as indicators of prognosis for recurrence. New molecular markers are needed for proper pre-treatment risk stratification of patients. Our aim was to assess the value of altered expression of syndecan-1 and -2 as a marker for predicting biochemical relapse in patients with clinically localized prostate cancer treated by radical prostatectomy. The expression of syndecan-1 and -2 was examined by immunohistochemical staining in a series of 60 paraffin-embedded tissue samples from patients with localized prostate cancer. Ten specimens from patients with benign prostatic hyperplasia were used as non-malignant controls. Semiquantitative analysis was performed to evaluate the staining patterns. To investigate the prognostic value, Kaplan–Meier survival curves were performed and compared by a log-rank test. In benign samples, syndecan-1 was expressed in basal and secretory epithelial cells with basolateral membrane localisation, whereas syndecan-2 was expressed preferentially in basal cells. In prostate cancer samples, the expression patterns of both syndecans shifted to granular-cytoplasmic localisation. Survival analysis showed a significant difference (P<0.05) between normal and altered expression of syndecan-1 and -2 in free prostate-specific antigen recurrence survival curves. These data suggest that the expression of syndecan-1 and -2 can be used as a prognostic marker for patients with clinically localized prostate cancer, improving the prostate-specific antigen recurrence risk stratification.

Keywords: biochemical recurrence; prostate cancer; syndecans

PDF | 中文摘要 |

Browse:  1120
Copyright 1999-2017  Shanghai Materia Medica, Shanghai Jiao Tong University.  All rights reserved